Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 1
2006 1
2009 1
2011 2
2012 1
2013 3
2015 3
2016 2
2017 3
2018 3
2019 3
2021 3
2022 3
2023 5
2024 4
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.
Smith MR, Hussain M, Saad F, Fizazi K, Sternberg CN, Crawford ED, Kopyltsov E, Park CH, Alekseev B, Montesa-Pino Á, Ye D, Parnis F, Cruz F, Tammela TLJ, Suzuki H, Utriainen T, Fu C, Uemura M, Méndez-Vidal MJ, Maughan BL, Joensuu H, Thiele S, Li R, Kuss I, Tombal B; ARASENS Trial Investigators. Smith MR, et al. N Engl J Med. 2022 Mar 24;386(12):1132-1142. doi: 10.1056/NEJMoa2119115. Epub 2022 Feb 17. N Engl J Med. 2022. PMID: 35179323 Free PMC article. Clinical Trial.
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
Powles T, Valderrama BP, Gupta S, Bedke J, Kikuchi E, Hoffman-Censits J, Iyer G, Vulsteke C, Park SH, Shin SJ, Castellano D, Fornarini G, Li JR, Gümüş M, Mar N, Loriot Y, Fléchon A, Duran I, Drakaki A, Narayanan S, Yu X, Gorla S, Homet Moreno B, van der Heijden MS; EV-302 Trial Investigators. Powles T, et al. N Engl J Med. 2024 Mar 7;390(10):875-888. doi: 10.1056/NEJMoa2312117. N Engl J Med. 2024. PMID: 38446675 Clinical Trial.
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.
Powles T, Csőszi T, Özgüroğlu M, Matsubara N, Géczi L, Cheng SY, Fradet Y, Oudard S, Vulsteke C, Morales Barrera R, Fléchon A, Gunduz S, Loriot Y, Rodriguez-Vida A, Mamtani R, Yu EY, Nam K, Imai K, Homet Moreno B, Alva A; KEYNOTE-361 Investigators. Powles T, et al. Lancet Oncol. 2021 Jul;22(7):931-945. doi: 10.1016/S1470-2045(21)00152-2. Epub 2021 May 26. Lancet Oncol. 2021. PMID: 34051178 Clinical Trial.
[Reply].
Egea-Mellado JM, Juan-Fita MJ, González-Gallego I, Fernández-Sánchez A. Egea-Mellado JM, et al. Among authors: juan fita mj. Med Clin (Barc). 2013 Sep 21;141(6):272-3. doi: 10.1016/j.medcli.2013.02.026. Epub 2013 May 10. Med Clin (Barc). 2013. PMID: 23669896 Spanish. No abstract available.
Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers.
Lozano R, Castro E, Lopez-Campos F, Thorne H, Ramirez-Backhaus M, Aragon IM, Cendón-Florez Y, Gutierrez-Pecharroman A, Salles DC, Romero-Laorden N, Lorente D, González-Peramato P, Calatrava A, Alonso C, Anido U, Arévalo-Lobera S, Balmaña J, Chirivella I, Juan-Fita MJ, Llort G, Y Cajal TR, Almagro E, Alameda D, López-Casas PP, Herrera B, Mateo J, Pritchard CC, Antonarakis ES, Lotan TL, Rubio-Briones J, Sandhu S, Olmos D. Lozano R, et al. Among authors: juan fita mj. Eur J Cancer. 2023 May;185:105-118. doi: 10.1016/j.ejca.2023.02.022. Epub 2023 Mar 5. Eur J Cancer. 2023. PMID: 36972661
A Newborn Screening Program for Sickle Cell Disease in Murcia (Spain).
Sánchez-Villalobos M, Campos Baños E, Juan Fita MJ, Egea Mellado JM, Gonzalez Gallego I, Beltrán Videla A, Berenguer Piqueras M, Bermúdez Cortés M, Moraleda Jiménez JM, Guillen Navarro E, Salido Fierrez E, Pérez-Oliva AB. Sánchez-Villalobos M, et al. Among authors: juan fita mj. Int J Neonatal Screen. 2023 Oct 10;9(4):55. doi: 10.3390/ijns9040055. Int J Neonatal Screen. 2023. PMID: 37873846 Free PMC article.
Prostate-specific Antigen at 3 Months as a Predictor of Radiologic Progression-free Survival in Metastatic Hormone-sensitive Prostate Cancer Treated with Apalutamide: Analysis of 633 Patients in a Real-world Database.
Hassi Roman M, Mate K, De Pablos-Rodriguez P, Horcajada ÁZ, Cascales AG, Bonet ÁS, Vilaseca A, Vázquez-Martul Pazos D, Espinós EL, Rodríguez JM, de la Morena Gallego JM, Alemán JR, Rivas JG, Formisano L, Juan Fita MJ, Planells MC, Esteban MD, Márquez MP, Sanz MG, Expósito NG, Picola N, Vives PS, Sutil RS, Climent Durán MA, Backhaus MR. Hassi Roman M, et al. Among authors: juan fita mj. Eur Urol Open Sci. 2024 Oct 17;70:58-63. doi: 10.1016/j.euros.2024.10.001. eCollection 2024 Dec. Eur Urol Open Sci. 2024. PMID: 39474116 Free PMC article.
Real-world prostate-specific antigen reduction and survival outcomes of metastatic hormone-sensitive prostate cancer patients treated with apalutamide: An observational, retrospective, and multicentre study.
López-Abad A, Ramírez Backhaus M, Server Gómez G, Cao Avellaneda E, Moreno Alarcón C, López Cubillana P, Yago Giménez P, de Pablos Rodríguez P, Juan Fita MJ, Climent Durán MÁ, Guardiola Ruiz I, Vidal Crespo N, Artés Artés M, Montoya Chinchilla R, Moreno Avilés J, Guzmán Martínez-Valls PL, López González PÁ. López-Abad A, et al. Among authors: juan fita mj. Prostate Int. 2024 Mar;12(1):20-26. doi: 10.1016/j.prnil.2023.10.003. Epub 2023 Nov 2. Prostate Int. 2024. PMID: 38523897 Free PMC article.
[Beginnings, evolution and current situation of the Newborn Screening Programs in Spain.].
Marín Soria JL, González de Aledo Castillo JM, Argudo Ramírez A, López Galera RM, Pajares García S, Ribes Rubió A, García Villoria J, Yahyaoui Macías R, Álvarez Ríos AI, Melguizo Madrid E, González Irazabal Y, Hernández de Abajo G, Prieto García B, Cardo González L, Martínez Morillo E, Robles Bauza J, Bauçà Rosselló JM, Pérez Esteban G, Díaz-Flores Estevez F, Pérez Mangas E, Cañadas Garzó V, Muñoz Boyero AC, Redondo Cardeña PA, Bueno Llarena MJ, Sánchez Alarcon J, Castiñeiras Ramos D, Cocho de Juan JÁ, Colón Mejeras C, Blanco Soto P, Cambra Conejero A, Fernández Ruano ML, Ortiz Temprado A, Egea Mellado JM, González Gallego I, Juan Fita MJ, Espada Saenz-Torre M, Rausell Felix D, Marcos Tomás JV, Ruiz Aja S, Delgado Pecellín C, Bóveda Fontán MD. Marín Soria JL, et al. Among authors: juan fita mj. Rev Esp Salud Publica. 2021 Feb 23;95:e202102041. Rev Esp Salud Publica. 2021. PMID: 33619242 Free article. Spanish.
35 results